MTD Study PXD-101 in Combination With Paclitaxel + Carboplatin in Chemotherapy-Naive Patients With Stage IV NSCLC
Conditions
- Stage IV Non-small Cell Lung Cancer
Interventions
- DRUG: Belinostat, Carboplatin, Paclitaxel
Sponsor
Acrotech Biopharma Inc.
Collaborators